← Back to Search

Other

mHealth Intervention for First Episode Psychosis

N/A
Waitlist Available
Led By Scott Stroup, MD, MPH
Research Sponsored by New York State Psychiatric Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 6 months
Awards & highlights

Study Summary

This trial will use smartphone technology to help prescribing medication for people with FEP. Data on symptoms and functioning will be collected in real-time to help make decisions on what will work best.

Eligible Conditions
  • First Episode Psychosis
  • Schizophrenia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
change of Client Satisfaction Questionnaire (CSQ-8) from baseline to 6 months
change of Treatment Satisfaction Questionnaire for Medication (TQSM) from baseline to 6 months

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: mHealth intervention groupExperimental Treatment1 Intervention
participants in the mHealth Group will download the app on to their smartphone and complete ecological momentary assessments on 3 consecutive weekdays every 2 weeks for 6 months.
Group II: Treatment as Usual groupActive Control1 Intervention
participants will undergo their routine treatment.

Find a Location

Who is running the clinical trial?

New York State Psychiatric InstituteLead Sponsor
475 Previous Clinical Trials
153,884 Total Patients Enrolled
Northwell Health, Early Treatment Program at Lenox HillUNKNOWN
The Institute for Family Health Center for Counseling at WaltonUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025